rs2287498
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common in clinvar |
Make rs2287498(A;A) |
Make rs2287498(A;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 17 |
Position | 7689242 |
Gene | TP53, WRAP53 |
is a | snp |
is | mentioned by |
dbSNP | rs2287498 |
dbSNP (classic) | rs2287498 |
ClinGen | rs2287498 |
ebi | rs2287498 |
HLI | rs2287498 |
Exac | rs2287498 |
Gnomad | rs2287498 |
Varsome | rs2287498 |
LitVar | rs2287498 |
Map | rs2287498 |
PheGenI | rs2287498 |
Biobank | rs2287498 |
1000 genomes | rs2287498 |
hgdp | rs2287498 |
ensembl | rs2287498 |
geneview | rs2287498 |
scholar | rs2287498 |
rs2287498 | |
pharmgkb | rs2287498 |
gwascentral | rs2287498 |
openSNP | rs2287498 |
23andMe | rs2287498 |
SNPshot | rs2287498 |
SNPdbe | rs2287498 |
MSV3d | rs2287498 |
GWAS Ctlg | rs2287498 |
GMAF | 0.1837 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
A study population including a total of 5,206 invasive ovarian cancer cases (2,829 of which were serous) and 8,790 controls found an association between rs2287498 and serous invasive cancer (median per allele odds ratio 1.30, CI: 1.07-1.57).[PMID 19276375]
[PMID 20386703] Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.
[PMID 23192612] Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
[PMID 22773013] Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population.
ClinVar | |
---|---|
Risk | rs2287498(A;A) |
Alt | rs2287498(A;A) |
Reference | Rs2287498(G;G) |
Significance | Probable-non-pathogenic |
Disease | not specified Li-Fraumeni syndrome Dyskeratosis Congenita |
Variation | info |
Gene | TP53 WRAP53 |
CLNDBN | not specified Li-Fraumeni syndrome Dyskeratosis Congenita, Recessive |
Reversed | 1 |
HGVS | NC_000017.10:g.7592560C>T |
CLNSRC | |
CLNACC | RCV000250737.1, RCV000319448.1, RCV000350559.1, |
[PMID 31387111] Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.